NCT00004149View on ClinicalTrials.gov

Arsenic Trioxide in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Previous Hormone Therapy

PHASE2CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

September 30, 1999

Primary Completion Date

August 31, 2003

Study Completion Date

August 31, 2003

Conditions
Prostate Cancer
Interventions
DRUG

arsenic trioxide

Trial Locations (3)

10029

Mount Sinai Medical Center, NY, New York

10461

Jacobi Medical Center, The Bronx

10467

Albert Einstein Clinical Cancer Center, The Bronx

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Albert Einstein College of Medicine

OTHER